<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/84918788492</prism:url><dc:identifier>SCOPUS_ID:84918788492</dc:identifier><eid>2-s2.0-84918788492</eid><prism:doi>10.1016/j.chembiol.2014.10.017</prism:doi><dc:title>IgGA: A “Cross-Isotype“ Engineered Human Fc Antibody Domain that Displays Both IgG-like and IgA-like Effector Functions</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>0</citedby-count><prism:publicationName>Chemistry and Biology</prism:publicationName><dc:publisher>Elsevier Ltd</dc:publisher><source-id>23405</source-id><prism:issn>10745521</prism:issn><prism:coverDate>2014-08-30</prism:coverDate><dc:creator><author auid="56189217500" seq="1"><ce:initials>W.</ce:initials><ce:indexed-name>Kelton W.</ce:indexed-name><ce:surname>Kelton</ce:surname><ce:given-name>William</ce:given-name><preferred-name><ce:initials>W.</ce:initials><ce:indexed-name>Kelton W.</ce:indexed-name><ce:surname>Kelton</ce:surname><ce:given-name>William</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56189217500</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng"><publishercopyright>© 2014 Elsevier Ltd.</publishercopyright><ce:para>All clinically approved antibodies are of the IgG isotype and mediate the clearance of target cells via binding to Fcγ receptors and complement (C1q). Even though IgA can elicit powerful cytotoxic action via FcαRI receptor binding, IgA antibodies have not been amenable to therapeutic development. Here, we report the engineering of a “cross-isotype“ antibody, IgGA, which combines the effector functions of both IgG and IgA. IgGA binds to FcαRI with an affinity comparable to that of IgA, and to the activating Fcγ receptors, FcγRI and FcγRIIa, with high affinity, and displays increased binding to C1q compared to IgG. Unlike trastuzumab-IgG, trastuzumab-IgGA potently activates both neutrophils and macrophages to kill Her2<sup>+</sup> cancer cells. Furthermore, IgGA mediates greater complement-dependent cytotoxicity than IgG1 or IgA antibodies. The multitude of IgGA effector functions could be important for therapeutic purposes and highlights the concept of engineering antibodies that combine effector functions from multiple antibody isotypes. Antibody isotype determines which immune processes are activated to clear antigenic targets via highly specific Fc receptor and complement protein interactions. Kelton etal. describe the engineering of a “cross-isotype“ Fc domain that combines receptor-binding features, and subsequent functions, of both IgG and IgA antibodies.</ce:para></abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/84918788492" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84918788492&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-84918788492%29" rel="cited-by"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"><affilname>University of Texas at Austin</affilname></affiliation><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60000264" id="60000264"><affilname>Nagoya University</affilname></affiliation><authors><author auid="56189217500" seq="1"><ce:initials>W.</ce:initials><ce:indexed-name>Kelton W.</ce:indexed-name><ce:surname>Kelton</ce:surname><ce:given-name>William</ce:given-name><preferred-name><ce:initials>W.</ce:initials><ce:indexed-name>Kelton W.</ce:indexed-name><ce:surname>Kelton</ce:surname><ce:given-name>William</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56189217500</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author><author auid="56450161700" seq="2"><ce:initials>N.</ce:initials><ce:indexed-name>Mehta N.</ce:indexed-name><ce:surname>Mehta</ce:surname><ce:given-name>Nishant</ce:given-name><preferred-name><ce:initials>N.</ce:initials><ce:indexed-name>Mehta N.</ce:indexed-name><ce:surname>Mehta</ce:surname><ce:given-name>Nishant</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56450161700</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author><author auid="56422400800" seq="3"><ce:initials>W.</ce:initials><ce:indexed-name>Charab W.</ce:indexed-name><ce:surname>Charab</ce:surname><ce:given-name>Wissam</ce:given-name><preferred-name><ce:initials>W.</ce:initials><ce:indexed-name>Charab W.</ce:indexed-name><ce:surname>Charab</ce:surname><ce:given-name>Wissam</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56422400800</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author><author auid="56450317800" seq="4"><ce:initials>J.</ce:initials><ce:indexed-name>Lee J.</ce:indexed-name><ce:surname>Lee</ce:surname><ce:given-name>Jiwon</ce:given-name><preferred-name><ce:initials>J.</ce:initials><ce:indexed-name>Lee J.</ce:indexed-name><ce:surname>Lee</ce:surname><ce:given-name>Jiwon</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56450317800</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author><author auid="56449679700" seq="5"><ce:initials>C.-H.</ce:initials><ce:indexed-name>Lee C.-H.</ce:indexed-name><ce:surname>Lee</ce:surname><ce:given-name>Chang-han</ce:given-name><preferred-name><ce:initials>C.h.</ce:initials><ce:indexed-name>Lee C.</ce:indexed-name><ce:surname>Lee</ce:surname><ce:given-name>Chang han</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56449679700</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author><author auid="56449977600" seq="6"><ce:initials>T.</ce:initials><ce:indexed-name>Kojima T.</ce:indexed-name><ce:surname>Kojima</ce:surname><ce:given-name>Takaaki</ce:given-name><preferred-name><ce:initials>T.</ce:initials><ce:indexed-name>Kojima T.</ce:indexed-name><ce:surname>Kojima</ce:surname><ce:given-name>Takaaki</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56449977600</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60000264" id="60000264"/></author><author auid="36016653200" seq="7"><ce:initials>T.</ce:initials><ce:indexed-name>Kang T.</ce:indexed-name><ce:surname>Kang</ce:surname><ce:given-name>TaeHyun</ce:given-name><preferred-name><ce:initials>T.</ce:initials><ce:indexed-name>Kang T.</ce:indexed-name><ce:surname>Kang</ce:surname><ce:given-name>TaeHyun</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/36016653200</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author><author auid="7101850711" seq="8"><ce:initials>G.</ce:initials><ce:indexed-name>Georgiou G.</ce:indexed-name><ce:surname>Georgiou</ce:surname><ce:given-name>George</ce:given-name><preferred-name><ce:initials>G.</ce:initials><ce:indexed-name>Georgiou G.</ce:indexed-name><ce:surname>Georgiou</ce:surname><ce:given-name>George</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7101850711</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60013372" id="60013372"/></author></authors></abstracts-retrieval-response>
